NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $34.5 million in its third quarter.
On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 30 cents.
The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The pharmaceutical company posted revenue of $36 million in the period, also falling short of Street forecasts. Seven analysts surveyed by Zacks expected $37.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI